Your browser doesn't support javascript.
loading
Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma.
Khalid, Bilal; Mukherjee, Sarbajit; Ibrahimi, Sami; Cannon, Trinitia; Gilles, Elizabeth; Moreau, Annie; Razaq, Mohammad.
Afiliación
  • Khalid B; Department of Medicine, Hematology-Oncology Section, The University of Oklahoma Health Sciences Center, Oklahoma City, OK.
  • Mukherjee S; Department of Medicine, Hematology-Oncology Section, The University of Oklahoma Health Sciences Center, Oklahoma City, OK.
  • Ibrahimi S; Department of Medicine, Hematology-Oncology Section, The University of Oklahoma Health Sciences Center, Oklahoma City, OK.
  • Cannon T; Departments of Otorhinolaryngology and.
  • Gilles E; Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK.
  • Moreau A; Department of Ophthalmology, The University of Oklahoma Health Sciences Center, Dean McGee Eye Institute, Oklahoma City, OK.
  • Razaq M; Department of Medicine, Hematology-Oncology Section, The University of Oklahoma Health Sciences Center, Oklahoma City, OK.
Am J Ther ; 25(3): e394-e396, 2018.
Article en En | MEDLINE | ID: mdl-29557803
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridinas / Neoplasias Cutáneas / Compuestos de Bifenilo / Carcinoma Basocelular / Receptor Smoothened / Anilidas / Antineoplásicos Límite: Humans / Male / Middle aged Idioma: En Revista: Am J Ther Asunto de la revista: TERAPEUTICA Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Piridinas / Neoplasias Cutáneas / Compuestos de Bifenilo / Carcinoma Basocelular / Receptor Smoothened / Anilidas / Antineoplásicos Límite: Humans / Male / Middle aged Idioma: En Revista: Am J Ther Asunto de la revista: TERAPEUTICA Año: 2018 Tipo del documento: Article